Prelude Capital Management’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,725
Closed -$278K 1277
2024
Q3
$278K Buy
+30,725
New +$278K 0.02% 813